Cephalexin oral suspension recalled for incorrect label dosage amount
Bryant Ranch Prepack is recalling Cephalexin oral suspension (125mg/5mL) due to back label errors stating the dose as 2.5g instead of the correct 5g per bottle. No illnesses have been reported.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class III labeling error involving incorrect dosage information with no reported illnesses or injuries. Per the severity rubric, FDA Class III recalls are typically scored 1 or 2, and minor labeling errors without reported harm are classified as Moderate (score 2).
Plain-English summary
Bryant Ranch Prepack, Inc. is recalling Cephalexin for Oral Suspension, USP, 125mg per 5mL in 200mL bottles due to labeling errors affecting the product's dosage information.
The back label of the affected bottles states 'Each contains: cephalexin monohydrate, USP equivalent to 2.5g' when it should state 'Each Bottle contains: cephalexin monohydrate, USP equivalent to 5g.' This discrepancy could affect how healthcare providers or patients understand the dosage of the medication.
The recall affects lot 234892 with an expiration date of 02/28/2025, distributed nationwide in the United States. The product is manufactured by Alkem Laboratories Ltd and relabeled by Bryant Ranch Prepack, Inc. of Burbank, California. Consumers who have received affected bottles should contact their healthcare provider or pharmacist for guidance. No illnesses or injuries related to this recall have been reported.
The recalled product
- Product
- CEPHALEXIN (CEPHALEXIN)
- Brand
- CEPHALEXIN
- Manufacturer
- Bryant Ranch Prepack, Inc.
- Category
- Drug — Oral Suspension
- Hazard
- mis-labeling
- incorrect-dosage
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot:234892
- Exp:02/28/2025.
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · CEPHALEXIN
- ModerateCephalexin Oral Suspension Recalled for Out-of-Specification Impurity
FDA (Drugs) · 2025-06-18
- ModerateCephalexin Oral Suspension Recalled for Chemical Impurity
FDA (Drugs) · 2025-06-18
- LowCephalexin Oral Suspension Recalled for Incorrect Labeling and Missing Dosage Information
FDA (Drugs) · 2024-06-12
- ModerateCephalexin Oral Suspension Recalled for Incorrect Dosage Label
FDA (Drugs) · 2024-06-12
- LowCephalexin for Oral Suspension Recalled for Back Label Error
FDA (Drugs) · 2024-06-12
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27